April, 2024
April 2024
Margaret Foti welcomes Lillian L. Siu to AACR as their President-Elect for 2024-2025
Mar 15, 2024, 10:20

Margaret Foti welcomes Lillian L. Siu to AACR as their President-Elect for 2024-2025

Margaret Foti shared a post on X/Twitter:

Dr. Siu’s visionary leadership as a researcher and clinician has led to transformative advancements in cancer research and patient care. I am thrilled that she has been elected AACR President-Elect, and I look forward to working with her to advance our mission.”

See the original announcement by AACR.
Source: Margaret Foti/X

Margaret Foti is the CEO of the American Association for Cancer Research (AACR). Under her leadership, AACR membership has grown from about 3,000 members to over 54,000 in 131 countries and territories, and the AACR’s portfolio of peer-reviewed scientific journals has increased from one to ten.

After beginning her AACR career in an editorial position with the journal Cancer Research, Foti progressed through several key editorial and management roles in scientific publishing to become chief executive officer. A graduate of Temple University, Foti is one of the most influential voices in advancing the field of cancer research, both in the United States and abroad.

Dr. Foti was elected president of three professional societies in scholarly publishing and in cancer research. She received numerous awards and distinctions, among them honorary degrees from the University of Rome La Sapienza, the University of Catania in Sicily and the University CEU of San Pablo in Madrid, Tara Withington Public Service Award from the Society for Immunotherapy of Cancer (SITC), 2018 Women for Oncology Award from the European Society for Medical Oncology, the 2016 James Ewing Layperson’s Award from the Society of Surgical Oncology.

In 2007, the AACR established the first AACR Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research, which is given annually in her name.

Lillian Siu is a Professor of Medicine at the University of Toronto (Canada), senior medical oncologist, Director of the Phase I Program, Co-Director of the Bras and Family Drug Development Program and the Clinical Lead for the Tumor Immunotherapy Program at the Princess Margaret Cancer Centre. She holds the BMO Chair in Precision Genomics (2016-2026).  Dr. Siu served on the Board of Directors for the American Society of Clinical Oncology (ASCO), was a member of the Nomination Committee for the American Association for Cancer Research (AACR) (2014-2016), and currently serves on the AACR Board of Directors. She is a scientific editor for Cancer Discovery and is on the editorial board for JAMA Oncology. She was also recognized as one of the 100 Influential Women in Oncology by OncoDaily.